Tiefenbacher New Market Launch: Bilastine as Oral Dispersible Tablet (ODT)

As the allergy season is in full swing, we at Tiefenbacher Group are thrilled to announce that we have successfully prepared the launch of our latest anti-allergy medicine, Bilastine Oral Dispersible Tablet (ODT) in Germany, which is now available in German pharmacies without prescription. We are particularly pleased to offer Bilastine (ODT) for the first time in 10mg strawberry flavoured tablets specifically for children aged 6-11 years.

Patients suffering from allergic symptoms such as hay fever, hives, urticaria, and other allergic reactions are hereby offered a more convenient and user-friendly way to control their allergy. The introduction of the oral dispersible tablet form is a response to the needs of patients who seek a more flexible and discreet way to manage their allergies, especially when on the go.

Bilastine Oral Dispersible Tablet (ODT) is designed to disintegrate quickly in the mouth without the need for water. This way patients who have difficulty swallowing pills or do not have immediate access to water can use it with ease.

The 10 mg tablets for children and the 20 mg tablets for adults have been developed in Tiefenbacher Group´s own laboratories and will be marketed by our partner, a well-known international pharmaceutical company. With the market entry of Bilastine Oral Dispersible Tablet we enable patients in Germany a better access to an important medicine which is currently available in pharmacies without a prescription needed.

Tiefenbacher Group is committed to continuously making high-quality medicines more affordable, more globally available, and better than before.